The metazoan protein BCL2-associated athanogene cochaperone 6 (Bag6) forms a hetero-trimeric complex with ubiquitin-like 4A (Ubl4A) and transmembrane domain recognition complex 35 (TRC35). This Bag6 complex is involved in tail-anchored protein targeting and various protein quality control pathways in the cytosol as well as regulating transcription and histone methylation in the nucleus. Here we present a crystal structure of Bag6 and its cytoplasmic retention factor TRC35, revealing that TRC35 is remarkably conserved throughout opisthokont lineage except at the C-terminal Bag6-binding groove, which evolved to accommodate a novel metazoan factor Bag6. Remarkably, while TRC35 and its fungal homolog guided entry of tail-anchored protein 4 (Get4) utilize a conserved hydrophobic patch to bind their respective C-terminal binding partners Bag6 and Get5, Bag6 wraps around TRC35 on the opposite face relative to the Get4-5 interface. We further demonstrate that the residues involved in TRC35 binding are not only critical for occluding the Bag6 nuclear localization sequence from karyopherin  binding to retain Bag6 in the cytosol, but also for preventing TRC35 from succumbing to RNF126-mediated ubiquitylation and degradation. The results provide a mechanism for regulation of Bag6 nuclear localization and the functional integrity of the Bag6 complex in the cytosol.
In this study, we present a crystal structure of a complex from humans that includes TRC35 and the TRC35-binding domain of Bag6. The structure of TRC35 reveals the conserved architecture relative to fungal Get4 homologs. Surprisingly, Bag6 utilizes the same conserved pockets on TRC35 that are recognized by Get5 on Get4; yet the extended domain wraps around the opposite face of the α-solenoid. The resulting interaction leads to masking of the bipartite NLS preventing nuclear trafficking of Bag6 by blocking binding to karyopherin α (KPNA), which is demonstrated experimentally. The interaction also prevents RNF126-mediated degradation of TRC35. The combined results suggest a mechanism for regulation of Bag6 nucleo-cytoplasmic distribution.
The crystal structure of TRC35 -Bag6-NLS complex
A complex between TRC35 (residues 23 to 305), previously shown to be competent for TA transfer (4) , and a minimal TRC35-binding domain of Bag6 that contains the NLS (residues 1000-1054) was co-expressed, purified and crystallized. A dataset from a single crystal was collected to 1.8Å resolution and phases were obtained using single wavelength anomalous dispersion from a rubidium derivative. The final model refined to 1.8-40Å had good statistics with an Rwork=15.8% and an Rfree=20.1% and no residues in the disallowed region of the Ramachandran. Full crystallographic statistics are provided in Table S1 . All TRC35 residues in the crystallized construct were visible in the electron density except for S137 and G138 that are disordered in the loop between 6 and 7. For Bag6, residues 1002-1043 were resolved with only a few terminal residues ambiguous in the electron density. TRC35 has the same overall architecture as the fungal Get4 structures (Fig. S1A) , revealing that the Get4 fold has been conserved across Opisthokonta. Opisthokonta includes metazoan, choanozoan, and fungal lineages ( Fig. S2) , which share common ancestry as determined by analysis of 16S-like rRNA sequences (27) and several protein sequences (28) . The first 15 -helices form an -solenoid fold that can be divided into Nand C-terminal halves (Fig. 1B) . Alignment of the NTD between TRC35 and Get4 (PDB ID: 3LKU) results in an RMSD = 1.380Å for that region, while the equivalent alignment in the CTD results in an RMSD = 3.429Å (Fig. S1B ). As seen in Get4 (14) , there is likely some flexibility between these two halves based on differences across crystal forms.
Get4/TRC35 and Get3/TRC40 are conserved throughout eukaryotic evolution and seem to occur as a pair in all opisthokonts, suggesting the essentiality of the two proteins in the pathway (Fig. S2 ). Consistent with this notion, residues at the TRC35-TRC40 interface (13) and the TRC35-Bag6 interface in TRC35 are highly conserved (Figs. S1C and S1D).
As predicted from sequence alignment analysis, the -hairpin in Get4 is replaced by a shorter loop in TRC35 (Fig. 1C, arrows) . In fact, sequence alignment of the predicted Get4 proteins of selected opisthokonts revealed that the -hairpin is unique to the fungal lineage (Figs. S2 and S3). The C-terminal 16 is flanked by two extended stretches that cover part of Bag6 (Fig. 1B) .
The Bag6 NLS region wraps around the TRC35-CTD ( Fig. 1B, light pink) at an interface that resembles the interaction of Get5 with Get4 (Fig. 1C) . The interaction is stabilized by two hydrophobic interface sites. In interface I, Bag6 1 and 2 dock into a conserved pocket created by 12 and 13 of TRC35 ( Fig. S1D ) and include W1004, V1008 and W1012 from Bag6 and V254, V257, F242, L258 and Y262 from TRC35 (Fig.   1D ). In fungal Get4-5, the Get5 N-terminal helix docks into a groove formed by 12, 13, and the -hairpin of Get4 (Fig. 1C) . The missing -hairpin in TRC35 results in the Bag6 helix shifting away from 11 towards 12 and 13 near the bottom of TRC35 (Fig. 1C , arrows). The differences in the interface result in changes in the arrangement of 11, 13, and 15 of TRC35 (Fig. 1C ) relative to those of Get4. Interface II is less extensive involving fewer residues, L1032, Y1036, M1040 of Bag6 and F195, M271 of TRC35 ( Fig.   1D ). While the connecting loops between the two interfaces are well-ordered in both contexts, the Bag6 loop makes fewer contacts to TRC35 than the extensive interactions in the Get5-loop to Get4 (Fig. 1B) .
The structure reveals how TRC35 masks the Bag6 bipartite NLS (Fig. 1B) . The conserved first basic cluster of the predicted NLS (K1024RVK) is sequestered between interfaces I and II (Fig. 1B, sticks) . Only the first lysine residue of the second cluster (K1043RRK) is resolved in our model ( Fig. 1B, sticks) . The truncated C-terminal residues of TRC35 in our construct are predicted to be disordered (29) and include conserved multiple negative charges (five Glu and three Asp (Fig. S3 )) that would be in position to mask the second NLS basic cluster, K1043RRK, through charge-mediated interactions.
Probing the Bag6-TRC35 Interface
To validate the interfaces observed in the structure, we generated alanine mutants for analysis by yeast 2-hybrid analysis. A fragment of Bag6 (residues 951-1126) was attached to the GAL4 transcription activating domain and full-length TRC35 was attached to the GAL4 DNA-binding domain. The transformation of both vectors were confirmed by cell growth on SC-Ura-Leu plates ( Fig. S4A & B) . Of the single amino acid substitutions (Figs. 2A, S4A & B), only one residue TRC35 (Y262A) at the end of interface I (Fig. 1D) disrupted the yeast 2-hybrid interaction (Fig. S4A ). The Bag6 mutations W1004A and W1012A localize at interface I and Y1036A localizes at interface II. While the individual mutations did not show a phenotype, the combination of the two mutations (W1004A/Y1036A or W1012A/Y1036A) synthetically disrupted the interaction ( Fig. 2A ).
For mutants that failed to grow, expression was confirmed by immunoblotting ( Fig. S4C ).
The results confirm that both interfaces are critical for forming a stable complex between Bag6 and TRC35.
We further validated the interaction of TRC35 with full length Bag6 in the context of a mammalian cellular environment. GFP-tagged wild-type (wt) Bag6 or the mutants Bag6(W1004A), Bag6(W1012), Bag6(Y1036A), Bag6(W1004A/Y1036A), and Bag6(W1012A/Y1036A) were co-expressed with FLAG-tagged TRC35 in CRISPRmediated Bag6 knock-out 293T cell (30) . Bag6 and associated proteins were captured from detergent-derived cell extracts by immunoprecipitating using a GFP-antibody.
Viewed by immunoblotting (Figs. 2B and S4D & E), each Bag6 mutation resulted in a reduction of the captured TRC35 relative to wtBag6 (compare lane 9 to lanes 10-12). The double mutants (lanes 13 &14) also had reduced capture of TRC35; however, by this assay they unexpectedly appeared to capture more TRC35 than the single mutants. In all the lanes, unexpected higher molecular weight TRC35 bands appeared that became more pronounced in the double mutants ( Fig. 2 asterisk and S4D & E). This will be discussed below. Overall, the general effect of mutations at the Bag6 interface are consistent between the yeast 2-hybrid and the mammalian pull-downs.
Improperly assembled TRC35 is ubiquitylated by RNF126
As noted above, examination of immunoprecipitation results (Figs. 2B and S4D & E) revealed two interesting observations: (1) an unexpected increase in TRC35 binding to Bag6 double mutants relative to single mutants ( Fig. 2B and S4D (18, 26) . Given the implication of Bag6 as a chaperone holdase in protein quality control processes such as mis-localized protein degradation (31) and ER-associated protein degradation pathways (20, 32) , we postulated that TRC35 mutants that fail to form a complex with Bag6 at its physiological binding site are unstable and become a target To verify a role for Bag6 in TRC35 degradation, Bag6 deficient cells were used to co-express TRC35, Bag6 variants and ubiquitin with the expectation that destabilized TRC35 would be ubiquitylated. Cells were transfected with TRC35•FLAG, Bag6•GFP, and HA•ubiquitin. Proteins bound to Bag6 were first immunoprecipitated with GFP antibody ( Fig. S5 A & B, lanes 2-7). To remove other ubiquitylated Bag6 substrates (20, 33, 34) , the samples obtained from the GFP immunoprecipitation were subject to a second round of immunoprecipitation using anti-FLAG beads under denaturing conditions ( Fig. S5A & B, lanes [9] [10] [11] [12] [13] [14] . Immunoblotting analysis of the samples from the first round of immunoprecipitation showed that all Bag6 variants pulled down ubiquitylated proteins, suggesting that these mutations did not affect its substrate-binding activity ( Fig. S5A Collectively, these data support the idea that the subset of TRC35 molecules unable to associate with Bag6 via the NLS domain are unstable and become targets for ubiquitindependent degradation through a client-chaperone interaction with Bag6. This suggests that the ubiquitylated TRC35 associates with the quality control module (QC) of Bag6 (36) .
To further ensure that unassembled TRC35 is a Bag6-QC substrate, we investigated the effect of the ubiquitin ligase RNF126 on TRC35 ubiquitylation. RNF126 is a Bag6-associated ubiquitin ligase utilized by the Bag6-QC for ubiquitylation of Bag6associated clients in the cytosol leading to their degradation by the proteasome (36) . If TRC35 ubiquitylation is mediated by Bag6-QC, knocking down RNF126 in cells expressing Bag6 mutants would result in reduced ubiquitylation of TRC35, increasing its stability. To test this hypothesis, the effect of RNF126 and proteasome inhibition on TRC35 ubiquitylation and stability were examined.
We examined the effect of siRNA-mediated RNF126 knockdown on TRC35 ubiquitylation. 293T cells co-expressing HA•ubiquitin, TRC35•FLAG and either wt or mutant Bag6•GFP (W1004A/Y1036A or W1012A/Y1036A) were treated with siRNA against RNF126 followed by 6 hour treatment with MG132. Bag6-associated TRC35 was isolated by two rounds of immunoprecipitation. Immunoblotting was used to analyze the relative ratio between ubiquitylated TRC35 and unmodified TRC35 (Ub-TRC35/TRC35).
The ratio in cells expressing both wtTRC35 and wtBag6 without RNF126 was defined as 
TRC35 Masks the Bipartite Nuclear Localization Sequence of Bag6 and Retains

Bag6 in the Cytosol
To investigate the Bag6-TRC35 interface in the context of Bag6 localization, the mutants identified from yeast 2-hybrid and immunoprecipitation were used for localization studies. Overexpression of TRC35 has been shown to retain Bag6 in the cytosol (20) , suggesting that TRC35 binding is required for cytosolic localization of Bag6. Because the mutations identified in our yeast 2-hybrid experiments specifically prevent TRC35 binding at its native binding site that contains the NLS, we postulated that exogenously expressed Bag6 mutants defective in TRC35 binding would localize primarily in the nucleus regardless of TRC35 expression. To test this hypothesis, wt and mutant Bag6 bearing a GFP tag were expressed in HeLa cells with or without TRC35•FLAG and the localization of Bag6 and TRC35 was examined by immunofluorescence.
As expected (20) , given the NLS, overexpressed wtBag6 and various Bag6 mutants were localized to the nucleus (Fig. 4A ). This is likely due to excess Bag6 that cannot be retained in the cytosol by endogenous TRC35. Indeed, when TRC35 is coexpressed with wtBag6, the increased cytosolic pool of TRC35 captures wtBag6 and both proteins stain primarily in the cytosol (Fig. 4A ). In accordance with the immunoprecipitation results ( Fig. 2B ), introduction of a single mutation-W1004A, table S3 ). These results unequivocally establish TRC35 as a cytoplasmic retention factor of Bag6.
TRC35 has higher affinity for Bag6 than Karyopherin-α 2 (KPNA2)
All molecules destined for the nucleus must move through the nuclear pore complex (NPC), a large assembly that spans the nuclear envelope and facilitates nucleocytoplasmic traffic (37) . Macromolecules larger than ~40 kDa cannot freely diffuse through the NPC and require carrier proteins, such as the karyopherin-α (KPNA) and -β families of transport receptors (38, 39) . The two basic clusters, R1024KVK and K1043RRK ( Fig. 5A ), in Bag6 are thought to act as a bipartite NLS by specifically recognizing the acidic substrate-binding surface of karyopherins (19) . In HeLa cells, the K1045R to S1045L mutation has been shown to abrogate nuclear localization of Bag6 (19) . Therefore, TRC35 and KPNA likely bind Bag6 at the fragment that contains the NLS.
To confirm that the Bag6-NLS is a KPNA binding site and to define the residues involved in KPNA binding, a Bag6 C-terminal 131 residues (Bag6C131) (40) in complex with hexahistidine-tagged full-length Ubl4A (Bag6C131-6xHis•Ubl4A) was purified from E. coli. KPNA2 was chosen specifically as it had been seen to interact with Bag6 (41) and could be stably purified. Mutations previously shown to abrogate Bag6 nuclear localization (19) were introduced at either the first basic cluster (1024SL) or the second basic cluster (1045SL) ( These results show that the residues required for binding KPNA2 are distinct from those required for binding TRC35 despite localizing between key TRC35 binding residues.
Moreover, unlike what had been previously suggested (19) , the Bag6 NLS is monopartite with the second basic cluster both necessary and sufficient for binding KPNA2. The overlap of the two binding sites provides a simple mechanism for Bag6 retention in the cytoplasm where TRC35 prevents KPNA binding by occlusion.
If binding of TRC35 to Bag6 prevents KPNA-mediated nuclear translocation, only TRC35-free Bag6 should be able to bind KPNA and be translocated to the nucleus. There are several ways in which this could be achieved. One such is that if KPNAs have a higher affinity for Bag6 than TRC35, upregulation of KPNA expression would lead to displacement of TRC35 from Bag6 and formation of a Bag6-KPNA complex. To test this, we compare the relative binding affinities of TRC35 and KPNA2 to Bag6 using an exchange assay. Bag6C131-6xHis•Ubl4A complexes with GST•TRC35 were generated and bound to glutathione affinity resin beads via the GST-tag. After washing, increasing amounts of MBP•KPNA2 were added to the bound beads. The ability of MBP•KPNA2 to displace Bag6C131-6xHis•Ubl4A from GST•TRC35 was determined by the amount of Bag6C131-6xHis•Ubl4A that was eluted from the resin after incubation. In this case, even at the highest concentration tested (2-fold molar excess), there was no significant displacement of Bag6 from TRC35 by KPNA2 ( Fig. 5C lanes 4-7) . Performing the opposite experiment, starting with MBP•KPNA2-Bag6C131-6xHis•Ubl4A on amylose beads, adding excess GST•TRC35 resulted in the dissociation of the MBP•KPNA2-Bag6C131-6xHis•Ubl4A complex ( Fig. 5C lanes 11-14) . These results highlight the stability of the TRC35-Bag6 complex and argue against the ability of KPNA regulation as a means for modulating the nuclear pool of Bag6.
Discussion
Bag6 is a critical scaffolding factor that forms a stable complex with TRC35 and Ubl4A and is involved in protein targeting, protein quality control, and transcription regulation. While there is ample evidence that Bag6 plays both cytosolic and nuclear roles, it is unclear how the localization of Bag6 is regulated. Here we report the structure of the Bag6 NLS-region bound to its cytosolic retention factor TRC35, and suggest a mechanism for the regulation of Bag6 localization.
The remarkable conservation of TRC35 in both sequence ( Fig. S3 ) and at the structural level ( Fig. S1 ) from yeast to human can be attributed to the role of TRC35 as a hub of protein-protein interactions in the TRC pathway. The most important interaction, based on its complete conservation, is between TRC35 and TRC40 ( Fig. S2 ) and likely drives evolution of components in the pathway. This interaction is critical for the regulation of TA protein transfer (4, 13, 42) and, as shown in fungal Get4, for release of Get3/TRC40 from the ER membrane to restore the cytosolic pool of complex ready for TA protein transfer (43) . The importance of linking TRC35 homologs to Ubl4A homologs is sustained in humans despite the loss of structural features that allow these two proteins to interact with each other (14) . In this case, the new component Bag6 is introduced, which acts as a scaffold to link TRC35 to Ubl4A. The Bag6-TRC35 structure reveals that TRC35 binds this novel binding partner utilizing conserved patches in a distinct fashion (Fig. 1) . This led to the expansion of the TRC35 protein-protein interaction network while maintaining its crucial interaction with TRC40.
Our results also show that TRC35 acts as an intermolecular mask to Bag6 NLS in a role similarly performed in other pathways. Examples of other cytosolic retention factor pairs include IκB and NF-κB (44), HIC and Rev (45) and BRAP2 that retains HMG20A (46) . Unlike other cytoplasmic retention factors, which have only been shown to bind their target NLS-containing proteins for occlusion of the NLS, TRC35 also plays a distinct role in the cytoplasmic TA targeting and protein quality control when in complex with Bag6.
This dual functionality may be evolutionarily conserved. One study showed that Ubl4A has a nuclear role of promoting STAT3 dephosphorylation (47) . This study did not explore the localization of Bag6 relative to Ubl4A, but Ubl4A does not have a NLS and thus is likely to have been translocated with Bag6. In yeast, fungal Get4 binds the N-terminal domain of Get5, which appears to contain a functional NLS that directs Get5 to the nucleus during a 'Get5-mediated stress response' (48) .
These results allow speculation of possible regulatory mechanism for Bag6 nuclear localization. First, disrupting the Bag6-TRC35 interface by introducing alanine mutations led to ubiquitylation of TRC35 (Fig. S4) , which is mediated by RNF126. Knocking down Bag6 has been shown to reduce levels of TRC35 in HeLa cells (26) , suggesting that Bag6 is required for TRC35 stability in vivo. We also showed that KPNA2 has a lower affinity for Bag6 than TRC35 (Fig. 5C ), which suggests that for Bag6 to bind KPNA and translocate into the nucleus, it needs to be free of TRC35. The most likely explanation is that cells regulate Bag6 localization by modulating Bag6 levels or decreasing TRC35 levels. In humans, the Bag6 rs3117582 single nucleotide polymorphism found in the promoter region of Bag6 likely affect expression levels and is associated with higher incidence of lung cancer (49) (50) (51) and osteoarthritis (52) . The localization could also be pre-translationally regulated with differential splicing. In brain and breast tissue, for instance, Bag6 isoforms that lack the NLS are expressed at higher levels than isoforms with the NLS (53).
Our findings establish TRC35 as a universally conserved protein in the opisthokont lineage in both structure and function. These findings support the model in which TRC35
is an important hub of a protein-protein interaction network with its interaction with TRC40 at the core. Higher eukaryotes expanded on this network by the addition of Bag6. Our biochemical studies unequivocally establish TRC35 as a cytosolic retention factor of Bag6 and suggest that Bag6 needs to be in excess for nuclear localization. However, how different cell types regulate Bag6 localization, whether the regulation can be mediated by specific stress, and the biological implications of differential distribution of Bag6 are important questions for future studies.
Materials and Methods
Detailed descriptions of experiments are provided in SI Materials and Methods. Briefly, for crystallization and in vitro binding assays human genes were subcloned and expressed in E. coli. Proteins were purified using affinity chromatography, anionexchange, and size-exclusion chromatography. Truncated fragments of Bag6 and TRC35 were crystallized and the structure was determined using molecular replacement single wavelength anomalous dispersion. The genomes were surveyed for TRC proteins using MEME suite (54) . The immunoprecipitation assays were carried out using 293T cell extracts. A combination of three siRNAs against RNF126 was added to 293T cells. 10 µM MG132 was added to inhibit the proteasome. Cos7 cells were used for localization assays. Hydrophobic residues that are involved in Bag6-TRC35 dimerization are shown as sticks. 296  296  271  304  291  276  286  270  320  279  388  299  296  302  305  281  270  328  261  314 Hsap 
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